Janssen Research & Development, L.L.C.
  • Home
  • Our Company
  • Our Innovation
  • Our Caring
  • Our Giving
  • Media Center

Site Map

  • Home
  • Our Company
    • Welcome
      • Bill Hait, Global Head
      • Paul Stoffels, Worldwide Chairman
    • Our History
      • Janssen Legacy
      • Dr. Paul Janssen Award
    • Locations
    • Careers
  • Our Innovation
    • Areas of Focus
      • Cardiovascular & Metabolism
      • Immunology
      • Infectious Diseases & Vaccines
      • Neuroscience
      • Oncology
      • Biotechnology
    • Clinical Trials
      • Clinical Data Transparency
    • Introduction to Drug Development
    • Collaborations
      • Janssen Labs at San Diego
  • Our Caring
    • Global Access and Partnership Program
    • Global Health
  • Our Giving
    • Focus Areas for Giving
    • Requirements to make a request
    • Online Submission
    • FAQs
    • Contact Us
  • Media Center
    • Newsroom
      • Press Releases
      • Archive
      • Media toolkits
        • Rivaroxaban Virtual Media Kit
  • Contact Us
  • Our Credo
  • Site Map
  • Contact Us
  • Legal Notice
  • Privacy Policy
  • Safe Harbor Agreement

Site Map

  • Site Map
  • Contact Us

Janssen Research & Development, LLC

  • Legal Notice
  • Privacy Policy
  • Safe Harbor Agreement

© Janssen Research & Development, LLC 2012. All Rights Reserved. Your use of the information on this site is subject to the terms of our Legal Notice. Please see our Privacy Policy. This site is published by Janssen Research & Development, LLC, which is solely responsible for its contents.This information is intended for use by our customers, patients and healthcare professionals in the United States only. Janssen Research & Development, LLC recognizes that the internet is a global communications medium; however, laws, regulatory requirements and medical practices for pharmaceutical products vary from country to country.

This page was last modified on May 01 2013.